Impact of timing of radium‑223 administration on the survival of patients with bone metastatic castration‑resistant prostate cancer

The present study aimed to evaluate the optimal timing of radium-223 chloride (Ra-223) administration among patients with bone metastasis from castration-resistant prostate cancer (BmCRPC). Patients, who were diagnosed with BmCRPC and treated with Ra-223 therapy between October, 2016 and January, 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Makita, Kenji, Hamamoto, Yasushi, Kanzaki, Hiromitsu, Yamashita, Natsumi, Nagasaki, Kei, Kido, Teruhito, Miura, Noriyoshi, Saika, Takashi, Hashine, Katsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391592/
https://www.ncbi.nlm.nih.gov/pubmed/37533801
http://dx.doi.org/10.3892/mi.2023.98

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391592/
https://www.ncbi.nlm.nih.gov/pubmed/37533801
http://dx.doi.org/10.3892/mi.2023.98

Ejemplares similares